2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Buy
57
AGX Quote, Financials, Valuation and Earnings
Last price:
$121.91
Seasonality move
:
7.52%
Day range:
$115.23 - $121.06
52-week range:
$48.19 - $191.46
Dividend yield:
1.13%
P/E ratio:
25.10x
P/S ratio:
2.05x
P/B ratio:
4.96x
Volume:
225.9K
Avg. volume:
408.4K
1-year change:
149.27%
Market cap:
$1.6B
Revenue:
$573.3M
EPS (TTM):
$4.78
Analysts' Opinion
-
Consensus RatingArgan has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $115.00, Argan has an estimated upside of 25% from its current price of $120.00.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $80.00 representing 100% downside risk from its current price of $120.00.
Fair Value
-
According to the consensus of 1 analyst, Argan has 25% upside to fair value with a price target of $115.00 per share.
AGX vs. S&P 500
-
Over the past 5 trading days, Argan has overperformed the S&P 500 by 7.9% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Argan does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Argan has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Argan reported revenues of $257M.
Earnings Growth
-
Argan has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Argan reported earnings per share of $2.00.
Enterprise value:
1.1B
EV / Invested capital:
--
Price / LTM sales:
2.05x
EV / EBIT:
16.69x
EV / Revenue:
1.39x
PEG ratio (5yr expected):
0.28x
EV / Free cash flow:
7.92x
Price / Operating cash flow:
11.65x
Enterprise value / EBITDA:
16.15x
Gross Profit (TTM):
$117M
Return On Assets:
10.07%
Net Income Margin (TTM):
8.2%
Return On Equity:
21.95%
Return On Invested Capital:
21.95%
Operating Margin:
11.8%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Income Statement | ||||||
| Revenue | $461.8M | $527.6M | $806.3M | $163.8M | $257M | |
| Gross Profit | $88.6M | $77.2M | $117M | $19.2M | $44.3M | |
| Operating Income | $38.8M | $34.3M | $67.3M | $7.9M | $30.3M | |
| EBITDA | $42.7M | $36.9M | $69.5M | $8.4M | $30.9M | |
| Diluted EPS | $1.50 | $2.50 | $4.78 | $0.40 | $2.00 | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $538.8M | $559.7M | $365M | $514.1M | $717.1M | |
| Total Assets | $595.5M | $613.2M | $410.9M | $563.7M | $768.9M | |
| Current Liabilities | $261M | $259M | $134.5M | $273.9M | $436.2M | |
| Total Liabilities | $264.8M | $263.4M | $139.2M | $278.8M | $440.2M | |
| Total Equity | $330.7M | $349.8M | $271.7M | $284.8M | $328.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$86.3M | $135.2M | $147.6M | $57.7M | $31.8M | |
| Cash From Investing | -$64.2M | -$62.7M | -$132.6M | -$70.3M | -$82.3M | |
| Cash From Financing | -$97.9M | -$27.1M | -$25.6M | -$5.6M | -$6.9M | |
| Free Cash Flow | -$89.2M | $132.3M | $141.7M | $56.6M | $29.2M | |
AGX
Sector
Market Cap
$1.6B
$611.3M
Price % of 52-Week High
62.68%
74.03%
Dividend Yield
1.13%
0%
Shareholder Yield
1.23%
2.49%
1-Year Price Total Return
149.27%
-5.84%
Beta (5-Year)
0.578
0.892
Dividend yield:
1.13%
Annualized payout:
$1.10
Payout ratio:
26.11%
Growth streak:
1 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$116.94
200-day SMA
Buy
Level
$112.06
Bollinger Bands (100)
Sell
Level
127.94 - 159.2
Chaikin Money Flow
Buy
Level
8.5M
20-day SMA
Sell
Level
$129.11
Relative Strength Index (RSI14)
Sell
Level
43.82
ADX Line
Sell
Level
24.71
Williams %R
Neutral
Level
-44.7292
50-day SMA
Sell
Level
$144.01
MACD (12, 26)
Sell
Level
-8.83
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Neutral
Level
10.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.3248)
Buy
CA Score
(Annual)
Level (0.3693)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-0.0139)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Argan Inc is a United States-base construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derive majority revenue.
Stock Forecast FAQ
In the current month, AGX has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The AGX average analyst price target in the past 3 months is $115.00.
-
Where Will Argan Stock Be In 1 Year?
According to analysts, the consensus estimate is that Argan share price will rise to $115.00 per share over the next 12 months.
-
What Do Analysts Say About Argan?
Analysts are divided on their view about Argan share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Argan is a Sell and believe this share price will drop from its current level to $80.00.
-
What Is Argan's Price Target?
The price target for Argan over the next 1-year time period is forecast to be $115.00 according to 1 Wall Street analyst, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is AGX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Argan is a Hold. 1 of 1 analysts rates the stock a Hold at this time.
-
How Can I Buy Shares Of AGX?
You can purchase shares of Argan via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Argan shares.
-
What Is The Argan Share Price Today?
Argan was last trading at $121.91 per share. This represents the most recent stock quote for Argan. Yesterday, Argan closed at $120.00 per share.
-
How To Buy Argan Stock Online?
In order to purchase Argan stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Is Goldman Sachs Stock a Buy Sell or Hold?
When the Federal Reserve started hiking rates in 2022, banks’…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
49
SMTC alert for Mar 17
Semtech [SMTC] is down 0.49% over the past day.
Buy
62
PLPC alert for Mar 17
Preformed Line Products [PLPC] is up 3.8% over the past day.
Sell
50
NUTX alert for Mar 17
Nutex Health [NUTX] is up 4.82% over the past day.
